(Q40850608)

24 September 2017

title

Reactogenicity and immunogenicity of three inactivated influenza virus vaccines in children (English)

1 reference

24 September 2017

R. N. Miles

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7320021

2 May 2024

C. W. Potter

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7320021

2 May 2024

A. Clark

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7320021

2 May 2024

R. Jennings

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7320021

2 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7320021

2 May 2024

publication date

1 October 1981

1 reference

full work available at URL

24 September 2017

https://api.elsevier.com/content/article/PII:S0092115781800297?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0092-1157(81)80029-7

https://api.elsevier.com/content/article/PII:S0092115781800297?httpAccept=text/plain

2 May 2024

1 reference

https://api.crossref.org/works/10.1016/S0092-1157(81)80029-7

Journal of Biological Standardization

2 May 2024

published in

1 reference

24 September 2017

volume

9

1 reference

24 September 2017

issue

4

1 reference

24 September 2017

page(s)

379-391

1 reference

Selective solubilization of hemagglutinin and neuraminidase from influenza viruses

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0092-1157%2881%2980029-7

7 January 2021

Comparative trial of influenza vaccines. II. Adverse reactions in children and adults

1 reference

https://api.crossref.org/works/10.1016%2FS0092-1157%2881%2980029-7

7 January 2021

A surface antigen influenza vaccine. 1. Purification of haemagglutinin and neuraminidase proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0092-1157%2881%2980029-7

7 January 2021

Reactogenicity and immunogenicity of a surface-antigen-adsorbed influenza virus vaccine in children

1 reference

https://api.crossref.org/works/10.1016%2FS0092-1157%2881%2980029-7

7 January 2021

Endotoxin content and clinical reactivity to influenza vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0092-1157%2881%2980029-7

7 January 2021

Influenza vaccine: split-product versus whole-virus types--How do they differ

1 reference

https://api.crossref.org/works/10.1016%2FS0092-1157%2881%2980029-7

7 January 2021

The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0092-1157%2881%2980029-7

7 January 2021

Reactogenicity and immunogenicity of whole and ether-Tween-split influenza A virus vaccines in volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0092-1157%2881%2980029-7

7 January 2021

Reactions and serologic responses in young children and infants after administration of inactivated monovalent influenza A vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0092-1157%2881%2980029-7

7 January 2021

Clinical studies of monovalent inactivated whole virus and subunit A/USSR/77 (H1N1) vaccine: serological responses and clinical reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0092-1157%2881%2980029-7

7 January 2021

Pulmonary infections complicating Asian influenza

1 reference

https://api.crossref.org/works/10.1016%2FS0092-1157%2881%2980029-7

7 January 2021

Reactogenicity and immunogenicity of inactivated influenza A (H1N1) virus vaccine in unprimed children. Report to the Medical Research Council Committee on influenza and other respiratory virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0092-1157%2881%2980029-7

7 January 2021

A new surface-antigen-adsorbed influenza virus vaccine. II. Studies in a volunteer group

1 reference

https://api.crossref.org/works/10.1016%2FS0092-1157%2881%2980029-7

7 January 2021

Determinants of immunity to influenza infection in man

1 reference

https://api.crossref.org/works/10.1016%2FS0092-1157%2881%2980029-7

7 January 2021

Influenza Virus Purification with the Zonal Ultracentrifuge

1 reference

https://api.crossref.org/works/10.1016%2FS0092-1157%2881%2980029-7

7 January 2021

Clinical reactions and serologic response following inactivated monovalent influenza type B vaccine in young children and infants

1 reference

https://api.crossref.org/works/10.1016%2FS0092-1157%2881%2980029-7

7 January 2021

Trials of Influenza A/New Jersey/76 Virus Vaccine in Normal Children: An Overview of Age-Related Antigenicity and Reactogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0092-1157%2881%2980029-7

7 January 2021

Evaluation of monovalent influenza vaccines. II. Observations during an influenza a-prime epidemic

13

1 reference

https://api.crossref.org/works/10.1016/S0092-1157(81)80029-7

2 May 2024

Identifiers

1 reference

24 September 2017

1 reference